HIGH

Dr. Reddy's Labs Recalls Varenicline Tablets Over Potency Issues

Dr. Reddy's Laboratories recalled 4,800 bottles of Varenicline tablets on November 11, 2025, due to sub potent drug levels. The affected lot failed stability tests, posing potential health risks to users. Consumers should stop using the product immediately and consult healthcare providers.

Quick Facts at a Glance

Recall Date
November 11, 2025
Hazard Level
HIGH
Brands
VARENICLINE TARTRATE, Dr. Reddys Laboratories Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Dr. Reddy's Laboratories, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Varenicline tablets are used as a prescription medication to help adults quit smoking by reducing withdrawal symptoms and cravings. Consumers typically buy this product as part of a smoking cessation plan.

Why This Is Dangerous

The recall is due to the drug being sub potent, meaning it might not deliver the intended effects in helping users quit smoking. This can lead to an ineffective treatment experience for those relying on the medication.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers may face health risks if they continue using the recalled Varenicline tablets. The urgency to discontinue use is high, as ineffective treatment could hinder smoking cessation efforts.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on the bottle.
  2. Verify if the lot number is F2400244 with an expiration date of October 31, 2026.
  3. If you possess the affected lot, stop using the product immediately.

Where to find product info

The lot number and expiration date can usually be found on the label of the bottle or packaging.

What timeline to expect

Expect a refund processing timeline of approximately 4-6 weeks after your request is submitted.

If the manufacturer is unresponsive

  • Contact Dr. Reddy's Laboratories customer service for assistance.
  • Follow up with a written request if there is no response within two weeks.

How to prevent similar issues

  • Always check for recalls before using prescription medications.
  • Consult your healthcare provider regularly about the effectiveness of your treatment.

Documentation advice

Document all correspondence with the manufacturer, including emails and phone calls. Keep receipts and photos of the product as proof of purchase.

Product Details

The recall affects Varenicline Tablets, 1mg, 56 tablets per bottle, distributed nationwide. The affected lot number is F2400244, with an expiration date of October 31, 2026.

Key Facts

  • Recall date: November 11, 2025
  • Report date: December 17, 2025
  • Quantity recalled: 4,800 bottles
  • Manufacturer: Dr. Reddy's Laboratories Inc.
  • Country of origin: India

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot # F2400244
Exp Date: 10/31/2026
UPC Codes
43598-022
43598-907
43598-908
+5 more
Affected States
ALL
Report Date
December 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more